ATA’s Year in Thyroidology: A Virtual Experience
February 19-20, 2021

Friday, February 19, 1:00 – 5:15 pm EST
Saturday, February 20, 11:00 am – 3:00 pm EST

Join us for the inaugural ATA Year in Thyroidology meeting.  Developed to provide you with succinct updates on the latest advances in research and clinical care, you’ll also have opportunities to ask the experts questions and network with other attendees.

Take advantage of this opportunity for a “best of” learning experience all from the convenience of your home or office.  Speakers are confirmed daily.  Meeting sessions include:

Friday, February 19, 2021

9:00 am – 1:00 pm – Directed Therapies for Thyroid Nodules Satellite Course (Separate registration required.  See below for agenda)

1:00 – 2:10 pm – New Therapeutics and Treatment Strategies for Advanced Thyroid Cancer

  • Maria E. Cabanillas, MD, MD Anderson Cancer Center
  • Lori J. Wirth, MD, Massachusetts General Hospital
  • Mark Zafereo, Jr., MD, MD Anderson Cancer Center

2: 15-3: 15 pm – Immunomodulators, Immunotherapies, and Their Effects on the Thyroid Gland

  • Melissa Lechner, MD, PhD, UCLA
  • Mabel M. Ryder, MD, Mayo Clinic

3:20 – 4:20 pm – Hypothyroidism and Combination Therapy

  • Antonio Bianco, MD, PhD, University of Chicago
  • Jacqueline Jonklaas, MD, PhD, Georgetown University
  • James V. Hennessey, MD, Beth Israel Deaconess Medical Center

4:30 – 5:15 pm – Meet the Professor Sessions

  • “Current status of active surveillance in the US”
    • Michael Tuttle, MD, Memorial Sloan Kettering
    • Allen Ho, MD, Cedars-Sinai Medical Center
  •  “Sneak Peek at the ATA guidelines for thyroid nodules and thyroid cancer”
    • Susan Mandel, MD, University of Pennsylvania
    • Matthew Ringel, MD, Ohio State University

Saturday, February 20, 2021

11:00 am – 12:05 pm – Thyroid Nodule Ultrasound Risk Stratification and the Promise of Artificial Intelligence

  • Jill Langer, MD, University of Pennsylvania
  • Naykky Singh Ospina, MD, University of Florida

12:10 – 1:00 pm – Non-Surgical Treatment of Benign Nodules

    • M. Regina Castro, MD, Mayo Clinic
    • Jung Hwan Baek, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center

1:05 – 2:05 pm – Trends in Managing Graves’ Disease

  • Juan P. Brito Campana, M.B.B.S., Mayo Clinic
  • Marius Stan, MD, Mayo Clinic

2:15 – 3:00 pm – Meet the Professor Sessions

  • “The de-escalation of care for thyroid nodules: progress and challenges”
    • Louise Davies, MD, MS, The Dartmouth Institute
    • Megan Haymart, MD, University of Michigan
  • “What’s new in thyroid surgery for 2021”
    • Martha A. Zeiger, MD, National Cancer Institute
    • Quan-Yang Duh, MD, University of California San Francisco

Satellite Workshop

Directed Therapies for Thyroid Nodules
Friday, February 19, 2021
9:00 am – 1:00 pm EST

Join Course Director Ralph P. Tufano, MD, MBA, FACS, Johns Hopkins University, and Co-Course Directors Jenifer Kuo, MD, MS, FACS, Columbia University and Leonardo Rangel, MD, Rio de Janeiro State University for a half-day workshop with lectures, live cases on Hydrodissection and Moving ShotTechniques and discussion on future directions.

Lecture Topics

  • ETOH ablation of Thyroid Nodules: Pearls and Pitfalls – Dev Abraham, MD, University of Utah 
  • What is RFA and How Does it Work? – Jonathon O. Russell, MD, FACS, Johns Hopkins University
  • Selecting the Right Patients for Directed Therapy – Kepal Patel, MD, FACS, NYU Langone Health
  • Optimizing Outcomes, Equipment and Setup of RFA – Jennifer Kuo, MD, MS, FACS, Columbia University
  • RFA Techniques for Benign Nodules: Live Cases Hydrodissection and Moving Shot Techniques – Leonardo Rangel, MD, State University of Rio de Janeiro
  • Future Directions: Parathyroid, PMC and Lymph Nodes – Catherine Sinclair, MD, Mount Sinai – New York
  • The Korean RFA Experience : Lessons Learned – Jung Hwan Baek, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center
  • Toxic Thyroid Nodules: RFA, Surgery or RAI? – Stefano Spiezia MD, Ospedale del Mare 
  • Case Discussions – Emad Kandil, MD, Tulane University, Jose Higino Steck MD, PhD, University of Campinas Medical School and Erivelto Volpi, MD, PhD, Medical College of Nove de Julho University 
  • Ultrasound Considerations for Directed TherapiesLisa Orloff, MD, Stanford Cancer Center
  • LASER ablation for Thyroid Nodules – Stefano Spiezia MD, Ospedale del Mare 

(Separate registration required)

Planning Committee

M. Regina Castro, MD, Co-Chair
Michael W. Yeh, MD, Co-Chair
Joshua Klopper, MD
Naykky Singh Ospina, MD
Jennifer A. Sipos, MD
Marius N. Stan, MD
Mark Zafereo, MD

Target Audiences

Endocrinologists, surgeons, PhDs, primary care physicians, physician assistants and nurse practitioners.


Please renew your ATA membership to take advantage of member rates.  A valid 2021 membership is required to take advantage of member rates.  Not a member?  Join today!

Click here to register today!

Category Early Bird (Through 1/15) Regular Registration (After 1/15)
Member Trainees $99 $149
Non Member Trainees $149 $199
Members $199 $249
Non Members $299 $349

Sponsorship Opportunities

Take advantage of this opportunity to reach clinicians from around the world and promote your products, devices, and technologies. From exhibits to product theaters, contact us at to learn more!

ATA Year in Thyroidology

ATA Members